Immuneering IMRX Balance Sheet (2020-2026)

NASDAQ IMRX
$4.89 -0.14 (-2.88%)
As of: Sep 4, 2026 · 12:49 PM EDT
Reported Financials

Immuneering Quarterly Balance Sheet

Periods 25 quarters
Latest Jun 2026

Immuneering reported total assets of $202.06M and total liabilities of $11.32M for the quarter ended Jun 2026, up 404.4% year over year. This balance sheet covers 25 quarters of results from Jun 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Accumulated Depreciation
0.16M0.17M0.22M0.28M0.34M0.42M
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
106.93M74.89M75.21M87.94M76.42M72.64M77.43M104.02M68.04M59.41M66.29M59.73M45.21M36.14M35.87M26.36M227.56M128.65M47.32M41.32M
Receivables - NetNet Receivables
0.47M0.25M0.28M0.18M0.07M0.01M0.00M
Receivables
0.47M0.25M0.28M0.18M0.07M0.01M0.00M
Prepaid Assets
3.36M2.89M1.48M0.89M2.76M3.21M2.70M2.52M3.34M3.42M3.17M3.96M4.60M3.44M2.34M1.37M1.54M3.41M4.72M8.09M
Current Assets
153.31M152.33M139.53M129.17M120.02M108.75M94.23M111.51M100.58M89.08M74.45M63.69M55.26M39.59M38.21M27.73M229.10M176.25M161.41M157.99M
Non-Current Assets
Property, Plant & Equipment (Net)
0.08M0.81M0.87M0.99M1.31M1.37M1.33M1.37M1.39M1.40M1.35M1.29M1.21M1.12M1.05M0.96M0.89M0.94M0.94M0.88M
Long-Term Investments
10.10M1.00M44.18M41.95M32.77M
Goodwill
6.70M6.69M6.69M6.69M6.69M6.69M6.69M6.69M6.69M6.69M6.69M6.69M6.69M6.69M6.69M6.69M6.69M6.69M6.69M
Intangibles
0.44M0.43M0.42M0.42M0.41M0.40M0.39M0.39M0.38M0.37M0.37M0.36M0.35M0.34M0.34M0.33M0.32M0.31M0.31M
Goodwill & Intangibles
7.14M7.12M7.11M7.11M7.10M7.09M7.08M7.08M7.07M7.06M7.06M7.05M7.04M7.03M7.03M7.02M7.01M7.00M7.00M
Other Non-Current Assets
0.01M0.10M0.09M0.09M0.74M0.74M0.74M0.74M0.74M1.03M1.22M1.23M1.30M1.30M0.81M0.84M0.63M0.28M0.28M0.28M
Non-Current Assets
10.73M14.37M12.92M12.88M13.67M13.62M13.46M13.39M13.30M13.50M13.54M13.40M13.30M13.13M12.48M12.33M11.95M55.74M53.40M44.06M
Assets
164.04M166.70M152.45M142.05M133.69M122.37M107.70M124.90M113.88M102.58M87.98M77.09M68.56M52.71M50.68M40.06M241.06M231.99M214.81M202.06M
Liabilities
Current Liabilities
Accounts Payables
1.80M1.39M1.64M1.24M2.34M3.15M2.72M2.69M1.94M2.11M2.27M2.62M1.94M1.96M1.31M2.40M1.60M1.54M1.45M3.38M
Payables
1.80M1.39M1.64M1.24M2.34M3.15M2.72M2.69M1.94M2.11M2.27M2.62M1.94M1.96M1.31M2.40M1.60M1.54M1.45M3.38M
Accumulated Expenses
3.39M3.97M1.72M2.23M4.56M4.50M2.41M2.43M3.30M5.17M2.58M3.76M4.59M4.97M3.39M4.51M7.48M7.84M3.06M4.09M
Other Accumulated Expenses
0.05M0.05M0.04M0.02M0.03M0.03M0.08M0.26M0.02M0.09M0.06M0.23M0.06M0.21M0.08M0.29M0.04M0.21M
Current Leases
0.08M0.27M0.27M0.29M0.31M0.38M0.36M0.33M0.30M0.30M0.30M0.31M0.32M0.34M0.35M0.37M0.38M0.40M0.41M0.43M
Total Current Liabilities
5.27M5.63M3.67M3.80M7.26M8.05M5.53M5.48M5.62M7.85M5.18M6.78M6.92M7.50M5.11M7.49M9.55M10.07M4.97M8.12M
Non-Current Liabilities
Preferred Stock Liabilities
Operating Leases
0.48M5.09M4.71M4.64M4.54M4.46M4.74M4.64M4.54M4.16M4.38M4.31M4.24M3.82M4.08M4.00M3.92M3.43M3.73M3.63M
Other Non-Current Liabilities
0.01M0.01M
Total Non-Current Liabilities
8.38M8.45M
Total Liabilities
5.75M10.72M8.39M8.46M11.80M12.52M9.91M9.79M9.86M12.01M9.26M10.78M10.84M11.33M8.84M11.12M13.08M13.50M8.29M11.32M
Shareholder's Equity
Common Equity
158.29M155.98M144.06M133.59M121.89M109.85M97.79M115.10M104.02M90.58M78.72M66.31M57.72M41.39M41.84M28.94M227.98M218.48M206.52M190.74M
Liabilities and Shareholders Equity
164.04M166.70M152.45M142.05M133.69M122.37M107.70M124.90M113.88M102.58M87.98M77.09M68.56M52.71M50.68M40.06M241.06M231.99M214.81M202.06M
Retained Earnings
206.76M215.28M216.37M217.45M218.55M219.64M221.15M250.66M252.16M253.81M256.26M257.92M263.93M265.65M281.15M282.68M496.65M498.66M500.48M502.13M
Treasury Shares